Profile data is unavailable for this security.
About the company
InventisBio Co Ltd is a China-based company primarily engaged in the research and development of innovative drugs. The Company’s main products are currently in clinical development. The Company's products focus on major disease areas such as oncology, metabolic diseases, and autoimmune diseases. Its products include D-0502, D-0120, D-2570, and BPI-D0316. The Company mainly conducts its businesses within domestic market.
- Revenue in CNY (TTM)180.53m
- Net income in CNY-116.28m
- Incorporated2013
- Employees185.00
- LocationInventisBio Co LtdNo.4 Building, Lane 67, Libing RoadSHANGHAI 201203ChinaCHN
- Phone+86 2 150778527
- Fax+86 2 150778527
- Websitehttps://www.inventisbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Yahong Meditech Co Ltd | 279.02m | -362.17m | 7.00bn | 391.00 | -- | 3.95 | -- | 25.10 | -0.642 | -0.642 | 0.4933 | 3.10 | 0.125 | 11.16 | 4.19 | 713,603.90 | -16.84 | -14.30 | -19.15 | -15.01 | 72.22 | 73.78 | -134.65 | -703.80 | 4.96 | -- | 0.1545 | -- | 1,365.55 | -- | 4.09 | -- | 50.48 | -- |
| GemPharmatech Co Ltd | 752.70m | 121.51m | 7.20bn | 1.58k | 58.37 | 3.27 | -- | 9.56 | 0.3007 | 0.3007 | 1.86 | 5.37 | 0.2807 | 4.51 | 1.88 | 476,993.40 | 4.53 | 7.69 | 5.42 | 8.96 | 61.84 | 68.17 | 16.14 | 25.58 | 3.17 | -- | 0.1295 | 21.94 | 10.39 | 28.94 | -30.89 | 25.88 | 20.02 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.02bn | 133.01m | 7.48bn | 1.36k | 54.96 | 6.43 | -- | 7.35 | 1.21 | 1.21 | 9.23 | 10.38 | 0.4745 | 35.48 | 1.28 | 653,956.40 | 6.04 | 11.39 | 10.49 | 18.82 | 48.60 | 53.31 | 12.72 | 19.66 | 1.78 | 9.97 | 0.3355 | 11.29 | 15.70 | 35.80 | -3.98 | 30.21 | 3.50 | -- |
| Shanghai Medicilon Inc | 1.08bn | -231.86m | 9.00bn | 2.27k | -- | 4.36 | -- | 8.34 | -1.75 | -1.75 | 8.04 | 15.36 | 0.3759 | 8.56 | 1.68 | 459,338.00 | -8.08 | 3.66 | -9.99 | 4.63 | 16.27 | 31.15 | -21.49 | 6.67 | 2.19 | -- | 0.1508 | 40.97 | -24.01 | 18.22 | -896.21 | -- | 2.54 | -- |
| Bio-Thera Solutions Ltd | 845.32m | -368.84m | 9.95bn | 1.17k | -- | 20.55 | -- | 11.77 | -0.8908 | -0.8908 | 2.04 | 1.17 | 0.3702 | 0.7722 | 5.96 | -- | -16.15 | -16.38 | -33.76 | -22.22 | 74.99 | 77.05 | -43.63 | -62.11 | 0.4617 | -34.12 | 0.573 | -- | 5.44 | 302.90 | -29.34 | -- | 11.14 | -- |
| HitGen Inc | 498.51m | 114.11m | 12.06bn | 483.00 | 106.64 | 8.20 | -- | 24.20 | 0.2824 | 0.2824 | 1.24 | 3.67 | 0.2726 | 6.37 | 4.69 | 1,032,114.00 | 6.18 | 3.06 | 6.87 | 3.36 | 55.23 | 53.55 | 22.67 | 14.48 | 5.12 | 6.59 | 0.1674 | 34.32 | 14.99 | 10.08 | 26.13 | -15.65 | 3.16 | -- |
| InventisBio Co Ltd | 180.53m | -116.28m | 13.53bn | 185.00 | -- | 8.13 | -- | 74.97 | -0.2012 | -0.2012 | 0.3122 | 2.88 | 0.0988 | -- | 1.03 | 975,824.70 | -6.36 | -32.89 | -6.76 | -35.22 | 99.41 | -- | -64.41 | -682.73 | -- | -- | 0.0127 | -- | -9.02 | 25.00 | 15.41 | -- | -3.97 | -- |
| Mabwell Shanghai Bioscience Co Ltd | 624.52m | -947.49m | 14.51bn | 1.36k | -- | 19.06 | -- | 23.23 | -2.37 | -2.37 | 1.56 | 1.90 | 0.1384 | 0.3458 | 14.57 | 441,048.00 | -21.06 | -29.90 | -36.19 | -36.18 | 88.72 | 85.56 | -152.14 | -1,188.68 | 0.8093 | -10.82 | 0.7353 | -- | 56.28 | 46.68 | 0.9031 | -- | 12.25 | -- |
| Sinocelltech Group Ltd | 1.89bn | -310.15m | 17.92bn | 2.28k | -- | -- | -- | 9.50 | -0.6964 | -0.6964 | 4.24 | -0.1083 | 0.5458 | 0.4325 | 3.04 | 828,989.10 | -8.37 | -22.66 | -29.60 | -48.25 | 93.51 | 95.52 | -15.33 | -42.96 | 0.5008 | -0.6753 | 1.02 | -- | 33.13 | 294.24 | 127.39 | -- | 23.95 | -- |
| BeBetter Med Inc | -100.00bn | -100.00bn | 19.09bn | 150.00 | -- | 88.65 | -- | -- | -- | -- | -- | 0.4785 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0116 | -- | -- | -- | 67.59 | -- | -- | -- |
Data as of Feb 10 2026. Currency figures normalised to InventisBio Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
25.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 25.07m | 6.00% |
| Foresight Fund Management Co., Ltd.as of 31 Mar 2025 | 13.17m | 3.30% |
| Ping An Fund Management Co., Ltd.as of 30 Jun 2025 | 10.53m | 2.52% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 10.09m | 2.42% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 9.97m | 2.39% |
| JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 2025 | 8.69m | 2.08% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 7.11m | 1.70% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 6.90m | 1.65% |
| National Council for Social Security Fundas of 31 Mar 2025 | 6.67m | 1.67% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 6.63m | 1.59% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
